Literature DB >> 31219950

Migraine understood as a sensory threshold disease.

Kuan-Po Peng1,2, Arne May1.   

Abstract

Migraine encompasses a broader spectrum of sensory symptoms than just headache. These "other" symptoms, eg, sensory phobias, cognitive and mood changes, allodynia, and many others indicate an altered sensitivity to sensory input which can be measured, in principle, by quantifying sensory threshold changes longitudinally over time. Photophobia, for example, can be quantified by investigating the discomfort thresholds towards the luminance of light. The aim of this review is to look into how thresholds change in patients with migraine. We performed a PubMed search up to June 2018 targeting all peer-reviewed articles evaluating the changes in threshold, sensory phobia, or sensitivity in patients with migraine. Migraineurs, in general, exhibit lower sensory thresholds compared with healthy controls. These threshold changes seem to follow the different phases during a migraine cycle. In general, thresholds reach a nadir when the headache starts (the ictal phase), rise after the headache ends, and then gradually descend towards the next attack. The sensory modality of measurement-mechanical, thermal, or nociceptive-and the location of measurement-trigeminal vs somatic dermatome-also influence the sensory threshold. Functional imaging studies provide evidence that the hypothalamo-thalamo-brainstem network may be the driving force behind the periodic threshold changes. In summary, there is evidence in the literature that migraine could be understood as a periodic sensory dysregulation originating from the brain. Nevertheless, the interstudy discrepancy is still high due to different study designs and a lack of focus on distinct migraine phases. Further well-designed and harmonized studies with an emphasis on the cyclic changes still need to be conducted.

Entities:  

Mesh:

Year:  2019        PMID: 31219950     DOI: 10.1097/j.pain.0000000000001531

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  16 in total

Review 1.  Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP.

Authors:  Diana N Krause; Karin Warfvinge; Kristian Agmund Haanes; Lars Edvinsson
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

2.  Active role of the central amygdala in widespread mechanical sensitization in rats with facial inflammatory pain.

Authors:  Mariko Sugimoto; Yukari Takahashi; Yae K Sugimura; Ryota Tokunaga; Manami Yajima; Fusao Kato
Journal:  Pain       Date:  2021-08-01       Impact factor: 6.961

Review 3.  Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: A narrative review.

Authors:  Antonia Klein; Christoph J Schankin
Journal:  Headache       Date:  2021-09-27       Impact factor: 5.311

4.  Association of plasma tryptophan concentration with periaqueductal gray matter functional connectivity in migraine patients.

Authors:  Kinga Gecse; Dóra Dobos; Csaba Sándor Aranyi; Attila Galambos; Daniel Baksa; Natália Kocsel; Edina Szabó; Dorottya Pap; Dávid Virág; Krisztina Ludányi; Gyöngyi Kökönyei; Miklós Emri; Gyorgy Bagdy; Gabriella Juhasz
Journal:  Sci Rep       Date:  2022-01-14       Impact factor: 4.379

5.  Intrinsic network connectivity reflects the cyclic trajectory of migraine attacks.

Authors:  Anne Stankewitz; Enrico Schulz
Journal:  Neurobiol Pain       Date:  2022-02-14

6.  Cervical musculoskeletal impairments in migraine.

Authors:  Zhiqi Liang; Lucy Thomas; Gwendolen Jull; Julia Treleaven
Journal:  Arch Physiother       Date:  2021-12-08

Review 7.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.

Authors:  Parisa Gazerani
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

8.  A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.

Authors:  Caroline M Kopruszinski; Edita Navratilova; Juliana Swiokla; David W Dodick; Iain P Chessell; Frank Porreca
Journal:  Cephalalgia       Date:  2020-09-26       Impact factor: 6.292

9.  Migraine: interactions between brain's trait and state.

Authors:  Edina Szabo; Stephen Green; Keerthana Deepti Karunakaran; Christine B Sieberg; Igor Elman; Rami Burstein; David Borsook
Journal:  CNS Spectr       Date:  2021-06-21       Impact factor: 3.790

10.  Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study.

Authors:  Gerrit L J Onderwater; Jitze Dool; Michel D Ferrari; Gisela M Terwindt
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.